Антирак. Новый образ жизни полностью

   35. Al Murri, A. M., J. M. S. Bartlett, P. A. Canney, et al., “Evaluation of an Inflammation-Based Prognostic Score (GPS) in Patients with Metastatic Breast Cancer,” British Journal of Cancer 94, no. 2 (2006): 227-30.

   36. Forrest, L. M., D. C. McMillan, C. S. McArdle, et al., “Comparison of an Inflammation-Based Prognostic Score (GPS) with Performance Status (ECOG) in Patients Receiving Platinum-Based Chemotherapy for Inoperable Non-Small-Cell Lung Cancer,” British Journal of Cancer 90, no. 9 (2004): 1704-6.

   37. Harris, R. E., S. Kasbari, and W. B. Farrar, “Prospective Study of Nonsteroidal Anti-inflammatory Drugs and Breast Cancer,” Oncology Reports 6, no. 1 (1999): 71-73.

   38. Nelson, J. E., and R. E. Harris, “Inverse Association of Prostate Cancer and Non-steroidal Anti-Inflammatory Drugs (NSAIDs): Results of a Case-Control Study,” Oncology Reports 7, no. 1 (2000): 169-70.

   39. Thun, M. J., “NSAID Use and Decreased Risk of Gastrointestinal Cancers,” Gastroenterology Clinics of North America 25, no. 2 (1996): 333-48.

   40. Karin, M., and F. R. Greten, “NF-kappaB: Linking Inflammation and Immunity to Cancer Development and Progression,” Nature Reviews Immunology 5, no. 10 (2005): 749-59.

   41. Marx, “Cancer Research.”

   42. Ibid.

   43. Calcagni, E., and I. Elenkov, “Stress System Activity, Innate and T Helper Cytokines, and Susceptibility to Immune-Related Diseases,” Annals of the New York Academy of Sciences 1069 (2006): 62-76.

   44. Glaser, R., “Stress-Associated Immune Dysregulation and Its Importance for Human Health: A Personal History of Psychoneuroimmunology,” Brain, Behavior, & Immunity 19, no. 1 (2005): 3-11.

   45. Beevor, A., Stalingrad: The Fateful Siege: 1942-1943 (New York: Penguin Group, 1998).

   46. Folkman, J., “Fighting Cancer by Attacking Its Blood Supply,” Scientific American , September 1996, 150-54.

   47. Folkman, J., “Tumor Angiogenesis: Therapeutic Implications,” New England Journal of Medicine 285, no. 21 (1971): 1182-86.

   48. Ibid.

   49.  “Cancer Warrior,” NOVA Online, 2001. (Accessed November 2, 2006, at

http://www.pbs.org/wgbh/nova/cancer/program.html.)

   50. O’Reilly, M. S., L. Holmgren, Y. Shing, et al., “Angiostatin: A Novel Angiogenesis Inhibitor That Mediates the Suppression of Metastases by a Lewis Lung Carcinoma,” Cell 79, no. 2 (1994): 315-28.

   51. O’Reilly, M. S., L. Holmgren, C. Chen, et al., “Angiostatin Induces and Sustains Dormancy of Human Primary Tumors in Mice,” Nature Medicine 2, no. 6 (1996): 689-92.

   52. Rose, D. P., and J. M. Connolly, “Regulation of Tumor Angiogenesis by Dietary Fatty Acids and Eicosanoids,” Nutrition and Cancer 37, no. 2 (2000): 119-27.

   53. Béliveau, R., and D. Gingras, Foods That Fight Cancer (New York: McClelland & Stewart Ltd., 2006).

   54. Béliveau, R., and D. Gingras, “Green Tea: Prevention and Treatment of Cancer by Nutraceuticals,” Lancet 364, no. 9439 (2004): 1021-22.

   55. Rose and Connolly, “Regulation of Tumor Angiogenesis by Dietary Fatty Acids and Eicosanoids.”

   56. Ziche, M., J. Jones, and P. M. Gullino, “Role of Prostaglandin E1 and Copper in Angiogenesis,” Journal of the National Cancer Institute 69, no. 2 (1982): 475-82.

   1. Dinse, G. E., D. M. Umbach, A. J. Sasco, et al., “Unexplained Increases in Cancer Incidence in the United States from 1975 to 1994: Possible Sentinel Health Indicators?” Annual Review of Public Health 20 (1999): 173-209.

   2. Institut de Veille Sanitaire, “Estimations Nationales: Tendances de l’Incidence et de la Mortalité par Cancer en France entre 1978 et 2000,” Ministère de la Santé, de la Famille et des Personnes Handicapées, 2002.

   3. Surveillance Epidemiology and End Results (SEER). Cancer incidence public use database, 2006; see http://seer.cancer.gov/.

   4. McGrath, K. G., “An Earlier Age of Breast Cancer Diagnosis Related to More Frequent Use of Antiperspirants/Deodorants and Underarm Shaving,” European Journal of Cancer Prevention 12, no. 6 (2003): 479-85.

   5. Steliarova-Foucher, E., C. Stiller, P. Kaatsch, et al., “Geographical Patterns and Time Trends of Cancer Incidence and Survival Among Children and Adolescents in Europe Since the 1970s (the ACCIS Project): An Epidemiological Study,” Lancet 364, no. 9451 (2004): 2097-2105.

   6. Post, P. N., D. Stockton, T. W. Davies, et al., “Striking Increase in Incidence of Prostate Cancer in Men Aged <60 Years Without Improvement in Prognosis,” British Journal of Cancer 79, no. 1 (1999): 13-17.

   7. Institut de Veille Sanitaire, “Estimations Nationales.”